Influence of NSCLC on secondary oxygen species production in animal or patient sera
Cancers induce oxidative stress at any step of their development from induction to progression as well as treatments themselves. The individual has to adapt permanently to oxidative stress changes by the mean of modifying energy production something that in turn modifies oxidative stress. To help maintaining homeostasis it had been proposed to supplement cancer patients by exogenously given antioxidants. However we demonstrated that both oxidative stress and anti-oxidative response vary non linearly during cancer growth, the resulting antioxidant status differing also from one patient to the other. This suggests that oxidative stress and drugs aimed at restoring oxidative homeostasis should be monitored all along the patient care. We describe a new technology using singlet oxygen as a source of oxidants that demonstrates both experimentally and in patients the above statements during the course of NSCLC growth. We analyze and propose hypotheses linking experimental and clinical results obtained.
 Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-86.
 Doki Y, Murakami K, Yamaura T, et al. Mediastinal lymph node metastasis model by orthotopic intrapulmonary implantation of Lewis lung carcinoma cells in mice. Br J Cancer 1999; 79: 1121-6.
 Weiss J, Taylor G, Zimmermann F, et al. Collection of body fluids In: Krinke G, editor. The Laboratory Rat. 2000 ed. London: Academic Press; 2000. p. 485-510.
 Olivier D, Douillard S, Lhommeau I, et al. Secondary oxidants in human serum exposed to singlet oxygen: the influence of hemolysis. Photochem Photobiol Sci 2009; 8: 1476-86.
 Bigot E, Bourcier R, Rozec B, et al. Photodynamic reactions as a marker of cerebral vascular diseases. In: Kostron H, Hasan T, editors. Photodynamic Medicine: From bench to clinic: Royal Society of Chemistry; 2016. p. 591-9.
 Bigot E, Bataille R, Patrice T. Increased singlet oxygen-induced secondary ROS production in the serum of cancer patients. J Photochem Photobiol B 2012; 107: 14-9.
 Czernichow S, Vergnaud AC, Galan P, et al. Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults. Am J Clin Nutr 2009; 90: 329-35.
 Meister A. Glutathione, ascorbate, and cellular protection. Cancer Res 1994; 54: 1969s-75s.
 Traber MG, Stevens JF. Vitamins C and E: beneficial effects from a mechanistic perspective. Free Radic Biol Med 2011; 51: 1000-13.
 Jacobs C, Hutton B, Ng T, et al. Is there a role for oral or intravenous ascorbate (vitamin C) in treating patients with cancer? A systematic review. Oncologist 2015; 20: 210-23.